Xlife Sciences AG (XLS) | WebDisclosure

PRESS RELEASE

published on 11/28/2025 at 13:10, 5 months 13 days ago

Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp

Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF

published on 10/16/2025 at 07:05, 6 months 27 days ago

Xlife Sciences AG publie son rapport ESG 2024 mettant en avant la croissance durable

Croissance Durable Responsabilité Sociale Impact Environnemental Xlife Sciences Rapport ESG 2024
BRIEF

published on 10/16/2025 at 07:05, 6 months 27 days ago

Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth

Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE

published on 10/16/2025 at 07:00, 6 months 27 days ago

Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core
Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector

Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report
BRIEF

published on 09/23/2025 at 07:05, 7 months 19 days ago

Xlife Sciences AG Focuses on VERAXA's NASDAQ Listing in H1 2025

Financial Performance Nasdaq Listing Global Partnerships Xlife Sciences Biotech Expansion
BRIEF

published on 09/23/2025 at 07:05, 7 months 19 days ago

Xlife Sciences AG se concentre sur l'introduction de VERAXA au NASDAQ au premier semestre 2025

Performance Financière Partenariats Mondiaux Xlife Sciences Cotation Au Nasdaq Expansion Biotechnologique
PRESS RELEASE

published on 09/23/2025 at 07:00, 7 months 19 days ago

Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization
Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025

Nasdaq Listing Xlife Sciences AG Internationalization VERAXA Biotech AG Half-Year Report 2025
BRIEF

published on 07/17/2025 at 07:05, 9 months 26 days ago

VERAXA Biotech AG progresse vers la cotation au NASDAQ grâce au dépôt du formulaire F-4

Cotation Au Nasdaq VERAXA Biotech Regroupement D'entreprises Dépôt Du Formulaire F-4 Thérapeutiques Oncologiques
BRIEF

published on 07/17/2025 at 07:05, 9 months 26 days ago

VERAXA Biotech AG Advances Toward NASDAQ Listing with Form F-4 Filing

Nasdaq Listing Business Combination Oncology Therapeutics VERAXA Biotech Form F-4 Filing
PRESS RELEASE

published on 07/17/2025 at 07:00, 9 months 26 days ago

Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4
Xlife Sciences AG's portfolio company VERAXA Biotech AG takes a key step towards NASDAQ listing with the filing of Form F-4, signaling continued momentum and billion-dollar valuation in the public market journey

Nasdaq Listing Business Combination Xlife Sciences AG VERAXA Biotech AG Form F-4

Published on 05/12/2026 at 06:00, 2 hours 18 minutes ago

NOA Lithium Announces Strategic Collaboration with Hidrotec to Support NOA Projects
Published on 05/12/2026 at 04:20, 3 hours 58 minutes ago

AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
Published on 05/12/2026 at 03:05, 5 hours 13 minutes ago

UraniumX Reports Tragic Incident at Its Zoo Bay Property
Published on 05/12/2026 at 00:00, 8 hours 18 minutes ago

PPX Mining Provides Update on Start-up of the Process Plant
Published on 05/12/2026 at 00:00, 8 hours 18 minutes ago

Redwood AI Included in Innovate BC Investor Showcase: BC's Top 25 Investible Companies Event

View all ACCESSWIRE

Published on 05/12/2026 at 08:05, 13 minutes ago

Bindex brings osteoporosis screening to Boots pharmacies
Published on 05/12/2026 at 08:00, 18 minutes ago

MBB SE increases adjusted EBITDA by 40% in the first quarter of 2026, exceeds €1 billion in equity for the first time and confirms its forecast
Published on 05/12/2026 at 08:00, 18 minutes ago

Viscom SE: A slow start to the 2026 financial year – positive performance expected later in the year; full-year forecast confirmed
Published on 05/12/2026 at 08:00, 18 minutes ago

Villeroy & Boch reports satisfactory quarterly result amid structural changes and geopolitical tensions
Published on 05/12/2026 at 08:00, 18 minutes ago

Transformation on track: CENIT shows significant increase in profitability in the first quarter of 2026

View all EQS

Published on 05/12/2026 at 07:20, 58 minutes ago

Q1 2026 Revenue
Published on 05/12/2026 at 07:20, 58 minutes ago

Chiffre d'affaires du T1 2026
Published on 05/12/2026 at 07:00, 1 hour 18 minutes ago

Hantavirus and health protection
Published on 05/12/2026 at 07:00, 1 hour 18 minutes ago

Hantavirus et protection sanitaire
Published on 05/11/2026 at 19:02, 13 hours 16 minutes ago

260511 BENETEAU Transactions sur actions propres

View all LES ECHOS COMFI WIRE

News